Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free AVTE Stock Alerts $22.17 +0.12 (+0.54%) (As of 04/22/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Aerovate Therapeutics Stock Price Performance5 Day Performance+2.64%1 Month Performance-14.00%3 Month Performance+9.43%6 Month Performance+101.00%Year-To-Date Performance-2.03%1 Year Performance+13.63% Receive AVTE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. AVTE Stock Chart for Tuesday, April, 23, 2024 AVTE Chart by TradingView Aerovate Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024$22.05$22.17+0.54%$22.87$21.35109,562 shs$617.66 million04/19/2024$21.60$22.05+2.08%$22.41$20.73218,786 shs$614.31 million04/18/2024$22.50$21.60-4.00%$22.44$20.96216,299 shs$601.78 million04/17/2024$23.62$22.50-4.74%$23.97$21.81159,191 shs$626.85 million04/16/2024$25.30$23.62-6.64%$25.58$23.47132,905 shs$658.05 million04/15/2024$25.24$25.30+0.24%$25.35$24.32106,784 shs$704.86 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/12/2024$26.89$25.24-6.14%$27.11$24.44133,111 shs$703.19 million04/11/2024$27.01$26.89-0.44%$27.05$26.53142,551 shs$749.16 million04/10/2024$28.05$27.01-3.71%$27.79$26.22223,391 shs$752.50 million04/09/2024$26.48$28.05+5.93%$28.68$26.41132,128 shs$781.47 million04/08/2024$25.05$26.48+5.71%$26.58$24.51119,804 shs$737.73 million04/05/2024$29.10$25.05-13.92%$28.00$24.43246,223 shs$697.89 million04/04/2024$29.12$29.10-0.07%$30.29$28.77153,814 shs$810.73 million04/03/2024$29.58$29.12-1.56%$30.23$28.27179,635 shs$811.28 million04/02/2024$30.75$29.58-3.80%$29.97$28.45169,282 shs$824.10 million04/01/2024$29.57$30.75+3.99%$32.42$28.29295,749 shs$856.70 million03/29/2024$29.57$29.57$29.99$27.10216,915 shs$823.82 million03/28/2024$28.50$29.57+3.75%$29.99$27.10216,915 shs$823.82 million03/27/2024$25.65$28.50+11.11%$29.36$25.62922,344 shs$788.60 million03/26/2024$26.95$25.65-4.82%$27.32$24.27271,347 shs$709.74 million03/25/2024$25.78$26.95+4.54%$28.39$26.26224,601 shs$745.71 million03/22/2024$26.00$25.78-0.85%$26.78$25.4090,512 shs$713.33 million03/21/2024$25.89$26.00+0.42%$27.00$25.69188,505 shs$719.42 million03/20/2024$25.72$25.89+0.66%$27.34$25.36102,945 shs$716.38 million03/19/2024$26.39$25.72-2.54%$26.97$25.07100,094 shs$711.65 million03/18/2024$26.70$26.39-1.16%$27.12$25.24191,434 shs$730.21 million03/15/2024$24.29$26.70+9.92%$27.37$24.41105,613 shs$738.79 million03/14/2024$26.98$24.29-9.97%$26.87$23.9573,639 shs$672.08 million03/13/2024$24.14$26.98+11.76%$27.82$23.06104,171 shs$746.54 million03/12/2024$24.77$24.14-2.54%$25.20$23.28302,228 shs$667.95 million03/11/2024$26.52$24.77-6.60%$26.35$24.13124,970 shs$685.39 million03/08/2024$24.40$26.52+8.69%$27.20$23.52105,083 shs$733.81 million03/07/2024$23.87$24.40+2.22%$25.85$23.46143,651 shs$675.15 million03/06/2024$22.84$23.87+4.51%$24.10$22.3742,483 shs$660.48 million03/05/2024$22.49$22.84+1.56%$23.22$22.0644,281 shs$631.98 million03/04/2024$23.83$22.49-5.62%$23.96$22.4251,021 shs$622.30 million03/01/2024$23.08$23.83+3.25%$24.24$22.20108,483 shs$659.38 million02/29/2024$23.09$23.08-0.04%$24.17$22.3351,983 shs$638.60 million02/28/2024$23.77$23.09-2.86%$24.19$22.2251,375 shs$638.90 million02/27/2024$20.74$23.77+14.61%$24.49$19.99163,559 shs$657.72 millionDon’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him02/26/2024$19.63$20.74+5.65%$21.63$18.0870,687 shs$573.88 million02/23/2024$18.82$19.63+4.30%$20.10$18.8182,065 shs$543.16 million02/22/2024$18.85$18.82-0.16%$19.20$18.3995,812 shs$520.75 million02/21/2024$18.80$18.85+0.27%$19.44$18.11184,675 shs$521.58 million02/20/2024$20.91$18.80-10.09%$21.00$18.08219,186 shs$520.20 million02/19/2024$20.91$20.91$22.28$20.8180,200 shs$578.56 million02/16/2024$21.64$20.91-3.37%$22.28$20.8180,254 shs$578.58 million02/15/2024$19.25$21.64+12.42%$21.69$18.4765,784 shs$598.76 million02/14/2024$19.00$19.25+1.32%$19.86$18.0843,059 shs$532.65 million02/13/2024$20.40$19.00-6.86%$20.35$18.6990,466 shs$525.73 million02/12/2024$21.45$20.40-4.90%$22.20$20.0891,608 shs$564.47 million02/09/2024$20.53$21.45+4.48%$22.20$20.3487,966 shs$593.52 million02/08/2024$20.59$20.53-0.29%$22.00$18.9958,796 shs$568.07 million02/07/2024$19.97$20.59+3.10%$21.06$19.5152,401 shs$569.73 million02/06/2024$18.14$19.97+10.09%$20.23$17.9550,624 shs$552.57 million02/05/2024$17.95$18.14+1.06%$18.50$16.9453,519 shs$501.93 million02/02/2024$18.69$17.95-3.96%$18.48$16.74140,816 shs$496.68 million02/01/2024$19.31$18.69-3.21%$19.50$18.2562,916 shs$517.15 million01/31/2024$18.83$19.31+2.58%$20.64$18.8270,466 shs$534.29 million01/30/2024$18.10$18.83+4.03%$19.08$17.8756,645 shs$520.89 million01/29/2024$17.68$18.10+2.35%$18.33$17.4196,533 shs$500.69 million01/26/2024$18.35$17.68-3.65%$19.00$17.05183,280 shs$489.19 million01/25/2024$19.15$18.35-4.18%$19.99$18.01705,897 shs$507.75 million01/24/2024$20.26$19.15-5.48%$20.68$18.7083,321 shs$529.88 million01/23/2024$20.00$20.26+1.30%$21.22$19.5054,282 shs$560.59 million01/22/2024$20.27$20.00-1.33%$20.84$19.4164,769 shs$553.40 million Related Companies: Longboard Pharmaceuticals Stock Chart Bicycle Therapeutics Stock Chart Y-mAbs Therapeutics Stock Chart Pharming Group Stock Chart ORIC Pharmaceuticals Stock Chart Silence Therapeutics Stock Chart SIGA Technologies Stock Chart Zymeworks Stock Chart PureTech Health Stock Chart Praxis Precision Medicines Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.